---
schema_version: "secwatch.filing_event.v1"
accession: "0001740797-24-000015"
form_type: "8-K"
ticker: "AVAI"
cik: "0001740797"
company_name: "AVAI BIO, INC."
filed_at: "2024-04-26T23:59:59+00:00"
generated_at: "2026-06-03T06:35:23.535351+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Avant Technologies CEO & COO resign; William Hisey named Interim CEO

## Summary
- Timothy Lantz resigned as CEO and Director effective April 24, 2024, without conflicts with the Board.
- Angela Harris resigned as COO and Jared Pelski as VP Business Development, effective April 24, 2024.
- William Hisey appointed Interim CEO effective April 25, 2024; base salary $4,000/month plus quarterly RSA of 70,000 shares.
- All three prior employment agreements (Lantz, Pelski, Harris) canceled by mutual consent; no claims outstanding.

## SEC filing metadata
- accession: 0001740797-24-000015
- form_type: 8-K
- ticker: AVAI
- cik: 0001740797
- company_name: AVAI BIO, INC.
- filed_at: 2024-04-26T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1740797/000174079724000015/0001740797-24-000015-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1740797/000174079724000015/avai8k_.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001740797-24-000015
- JSON: https://secwatch.observer/filing/0001740797-24-000015.json
- Plain text: https://secwatch.observer/filing/0001740797-24-000015.txt

## Key facts
- Executive change
  Timothy Lantz resigned as Director at AVAI BIO, INC..
  - Action: resigned
  - Role: Director
  source text: Effective April 24, 2024, Mr. Lantz vacated his positions as CEO and Director of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1740797/000174079724000015/0001740797-24-000015-index.htm
- Executive change
  Jared Pelski resigned as Vice President – Business Development at AVAI BIO, INC..
  - Action: resigned
  - Role: Vice President – Business Development
  source text: Effective April 24, 2024, Jared Pelski resigned as Vice President – Business Development of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1740797/000174079724000015/0001740797-24-000015-index.htm
- Executive change
  Timothy Lantz resigned as Chief Executive Officer at AVAI BIO, INC..
  - Action: resigned
  - Role: Chief Executive Officer
  source text: Effective April 24, 2024, Mr. Lantz vacated his positions as CEO and Director of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1740797/000174079724000015/0001740797-24-000015-index.htm
- Executive change
  William Hisey was appointed as Interim Chief Executive Officer at AVAI BIO, INC..
  - Action: appointed
  - Role: Interim Chief Executive Officer
  source text: William Hisey – Interim CEO Appointment: On April 24, 2024, Avant Technologies, Inc. (the 'Company') and William Hisey entered into an Employment Agreement pursuant to which Mr. Hisey was retained as Interim Chief Executive Officer ('CEO').
  evidence_url: https://www.sec.gov/Archives/edgar/data/1740797/000174079724000015/0001740797-24-000015-index.htm
- Executive change
  Angela Harris resigned as Chief Operating Officer at AVAI BIO, INC..
  - Action: resigned
  - Role: Chief Operating Officer
  source text: Effective April 24, 2024, Angela Harris resigned as Chief Operating Officer ('COO') of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1740797/000174079724000015/0001740797-24-000015-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.